INTRODUCTION
Idiopathic Parkinson's disease (PD) is characterised by the selective loss of dopamine neurons in the substantia nigra and is responsive to the exogenous administration of levodopa (L-DOPA) (Litvan et al. 2007 ). The neurons that degenerate contain the rate-limiting enzyme for dopamine synthesis, tyrosine hydroxylase (TH). Growth factors, including insulin-like growth factors (IGF) can protect against environmental toxins used to produce animal models of PD (Quesada and Micevych 2004; Chung et al. 2005) . While the cause/s of PD remain unknown, there is evidence that complex interactions between genetic susceptibility and environmental exposures are involved (Le Couteur et al. 2002) . In particular, the genetic component of PD is postulated to be a combination of small incremental risks from common variants of multiple genes. Linkage disequilibrium-based mapping approaches, such as haplotype analysis, allow this common disease -common variant hypothesis to be investigated using a minimal amount of markers per loci (Doris 2002) . (Rodriguez et al. 2004) . Associations were subsequently found between particular IGF2-INS-TH haplotypes and cardiovascular risk factors, such as high body fat percentage, plasma triglycerides and blood pressure (Rodriguez et al. 2004 ) and initiation of regular smoking (Rodriguez et al. 2006) . This latter study supported other groups who found associations between the HUMTH01 marker per se and smoking behaviour Olsson et al. 2004) . Interestingly, these same risk factors occur less frequently in PD patients compared with controls (Haugarvoll et al. 2005; Scigliano et al. 2006) , suggesting that common variants in the IGF2-INS-TH gene cluster may also affect susceptibility for PD. The TH gene has been previously discounted as a PD susceptibility gene, although only single polymorphic markers were investigated in these studies (PlanteBordeneuve et al. 1994; Kunugi et al. 1998; Mizuta et al. 2006) . Furthermore the potential confounding influence of smoking behaviour was not considered in these studies. We therefore investigated the potential role of IGF2, INS and TH genes, along with the known protective factor smoking, in PD susceptibility. 
MATERIALS AND METHODS

Case recruitment and phenotyping
Caucasian PD cases were recruited by an experienced neurologist (PS) at both private and public movement disorders clinics in Brisbane, Australia. Informed consent for participation in the study was obtained following approval by the human research ethics committees at each of the participating institutions, in accordance with the Declaration of Helsinki. Standard criteria for the diagnosis of probable PD was used (Gelb et al. 1999) . Patients were excluded if they had no response to levodopa, or they had cognitive decline. A standard questionnaire was completed to obtain detailed epidemiological information including smoking behaviour.
Subjects were considered smokers if they had ever smoked at least one cigarette per day for a period of a year or more (Deng et al. 2004) . Controls of Caucasian ancestry were a combination of spouses (37%) and electoral roll volunteers who underwent the same data collection procedures and were excluded if screening responses suggested any possibility of movement or cognitive disorders. Blood was collected for subsequent DNA extraction from 215 PD cases (mean age = 71± S.D. of 9 years, M/F = 129/86) and 215 age and gendermatched controls (mean age = 71± 9 years, M/F = 129/86).
Genotyping
Design and implementation of genotyping assays for SNPs, rs680 and rs689, was carried out by the Australian Genome Research Facility in Brisbane, using the Sequenom Platform.
HUMTH01 PCR amplification (Sharma et al. 1998 ) was performed using the primers: has been previously described (Rodriguez et al. 2004 ).
Statistics
A nominal statistical significance level of < 0.05 was used for all tests unless modified for multiple comparisons using Bonferroni's correction. Hardy-Weinberg equilibrium analyses were performed (web-based χ 2 analyses:
http://www.kursus.kvl.dk/shares/vetgen/_Popgen/genetik/applets/kitest.htm) to assess genotyping reliability. Haplotype differences between PD cases and controls were assessed with χ 2 analysis using the 'EH' program (version 15; http://www.genemapping.cn/eh.htm).
The program utilises an expectation-maximisation algorithm to handle unphased data.
Haplotype crude odds ratios (OR) were calculated using a web-based calculator (http://statpages.org/ctab2x2.html). Linkage disequilibrium analysis was calculated using the '2LD' program (http://www.mrc-epid.cam.ac.uk/Personal/jinghua.zhao/software.htm)
incorporating 'EH' generated haplotype data. Uncommon haplotypes were combined to reduce cells and all other haplotypes used as the reference. Further explorative statistics to determine any underlying individual allelic or genotypic polymorphisms associated with PD were assessed using χ 2 analyses (SPSS Version 13.0). Binomial logistic regression modelling was used to adjust the ORs for age, gender, and smoking status. Variables that were significantly difference in these univariate regression analyses were included in a final multivariate regression model.
RESULTS
The rs680 and HUMTH01 markers were in Hardy-Weinberg equilibrium for both cases and control populations (p>0.6). The rs689 marker for cases was in Hardy-Weinberg equilibrium (p=0.6), but the controls were outside Hardy-Weinberg equilibrium for this marker (0.04).
However, there were no ambiguities between replicates for these samples. Eight common
IGF2-INS-TH
haplotypes accounted for 91% of all haplotypes among the controls (Table 1) .
A χ 2 analysis of all haplotype frequencies showed a significant difference between PD cases and controls (χ 2 = 20.4, degrees of freedom (df) = 8, p ≤ 0.01). Table S1 ) and 'AA'
homozygotes cases (OR = 0.37, 95% C.I. = 0.17-0.83, p-value = 0.02) ( Table 2) were significantly reduced among PD. As previously reported (Sharma et al. 1998) , five different HUMTH01 alleles (a, b, c, d and e) relating to 6, 7, 8, 9 and 9.3 TCAT repeats were observed in our group. A χ 2 analysis of all HUMTH01 alleles showed no significant differences (χ 2 = 7.45, df = 4, p-value ≥ 0.11) between cases and controls. However genotype analysis showed that 'e' allele carriers were under-represented among PD cases (non-corrected OR = 0.66, 95% C.I. = 0.45-0.97, p-value = 0.04) ( Table 2 and Supplementary Table S1 ).
*** Table 2 about here *** Finally a logistic multivariate regression analysis including the rs680 'AA' genotype and HUMTH01 'e' carrier genotypes was carried out. This suggested that the majority of the *6 protective effect was associated with rs680 (OR = 0.72, 95% C.I. = 0.53-0.98, p-value = 0.03) ( Table 3 ). The protective effect seen with HUMTH01 'e' allele carriers was reduced to a strong trend (OR = 0.68, 95% C.I = 0.46-1.01, p = 0.06) (Table 3) suggesting that the e allele also contributes to the outcome, albeit to a lesser extent. suggested that the rs680 'A' allele probably accounts for the majority of this effect as the significance of the HUMTH01 'e' carrier genotype was lost in this analysis (Table 3 ). There was modest linkage disequilibrium between the HUMTH01 and rs680 markers (D' = 0.48; p = 0) so it is possible that both may be proxies for the same functional entity with an influence on disease outcome. However, given that HUMTH01 'e' carrier status, adjusted for the influence of the rs680 genotype, continued to make a modest contribution to the outcome it seems more likely that there are at least two protective entities on the *6 background.
***
We did not find significant differences in the overall allele frequencies of the HUMTH01 microsatellite, consistent with previous negative case-control reports (Plante-Bordeneuve et al. 1994 ) (Supplementary Table S1 ). However HUMTH01 may act as a marker for causative variants rather than being a functional variant per se. In that case, the detection of subtle differences between common haplotypes in our study suggests that analysis of HUMTH01 alone gives an incomplete picture of the common genetic variation in and around the TH gene. While the 'e' allele of HUMTH01 features in the *6 haplotype, it is also seen on the *3 and *4 backgrounds, whose frequencies were similar between cases and controls in our study, thus diluting any independent association effect. This diluting effect could also explain the variation seen in previous in vitro and in vivo studies assessing HUMTH01's effect on TH expression. One in vitro study revealed a length-dependent reduction in transcription up to eight repeats (c allele) but no further reduction or enhancement of transcription with larger repeats (Albanese et al. 2001) . Their result suggests that the 'a' allele should be associated with the highest TH activity in vivo. However in vivo studies actually suggest that the longer 'e' allele has the highest enzyme activity (Sharma et al. 1998; Zhang et al. 2004) , although this finding also lacks consistency (Wei et al. 1997) .
TH gene variability has been linked to cardiovascular disease. The study of Sharma et al. (1998) showed that the 'e' allele was over represented in hypertensive individuals, consistent with *4 and *8 containing this allele being associated with elevated cardiovascular risk factors (Rodriguez et al. 2004) . Cardiovascular risk factors such as increased blood sugar, triglycerides, total lipids and systolic blood pressure occur significantly less frequently in PD compared with controls (Haugarvoll et al. 2005; Scigliano et al. 2006) , consistent with the observed *6 protective effect for PD (present study). Rather than a significant TH effect, Rodriguez et al. (2004) suggest that the long repeat insertion in the INS promoter contributes most to cardiovascular association with the IGF2-INS-TH haplotypes. In the present study we did not find any underlying association between the INS gene and PD.
Variability in the TH gene has also been linked to smoking behaviour. Smoking behaviour is negatively associated with PD (De Reuck et al. 2005; Wirdefeldt et al. 2005) . In non-PD Caucasian cohorts the HUMTH01 'b' allele confers protection against tobacco dependence Olsson et al. 2004 ). However we failed to see any over-representation of this allele in PD and were unable to find any differences in IGF2-INS-TH frequencies when smoking status and life-long cigarette smoking exposure in terms of pack-years were investigated as dependent variables in our cohort (data not shown). This may be due to our cohort being selected for PD, although we included smoking status as a covariant in our association studies.
The IGF2 gene or gene product has not been previously investigated in PD. The IGF2 gene is imprinted in prenatal development but both alleles are expressed in the adult human brain (Pham et al. 1998) . Our results suggest that a polymorphism in this gene or a causative entity in tight linkage disequilibrium with the rs680 'A' allele is protective for PD. The rs680 'A' allele has been associated with higher plasma IGF2 protein levels and lower body weights (O'Dell et al. 1997; Gaunt et al. 2001; Sandhu et al. 2003) . Interestingly, low body mass index, potentially reflecting a wider metabolic disturbance, is observed in PD (Bachmann and Trenkwalder 2006) , although plasma IGF2 levels have not been assessed in PD patients to our knowledge. The IGF2 gene has also been linked to the neurodegeneration in Alzheimer's disease where reduced levels of insulin, IGF1, and IGF2 and their receptors transcripts are seen with advancing stages of the disease (Rivera et al. 2005) .
As with all genetic association studies, there are many potential biases that can influence outcome and lead to false-positive findings, so replication of these findings in an independent sample is necessary for confirmation. The advantages of our study include the consistency of the genetic data from our tightly age and gender matched cases and controls, and the use of a validated questionnaire to assess non-genetic factors. In particular our genotyping data was comparable to other Caucasian cohorts for HUMTH01 Olsson et al. 2004; Rodriguez et al. 2006; Sharma et al. 1998 ) and both SNPs (Rodriguez et al. 2006) . Despite this, the rs689 SNP remained outside Hardy-Weinberg equilibrium in our control population even after replication. Admittedly our controls were a convenient sample of both electoral roll Sutherland et al. 11 volunteers and spouses, but the potential overmatching of the latter for environmental factors seems unlikely to affect our results.
Overall our results suggest that there is at least one common variant in the IGF2-INS-TH gene cluster that affects or is associated with susceptibility to PD. It remains unclear which gene in the cluster harbours this variant(s) and whether the effect is brain-specific or part of a more systemic syndrome. Tables   Table 1 . 
